InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Jalota Deepika, SVP, Affaires Réglementaires et QA. Director active across 1 company, notably PMV Pharmaceuticals, Inc.. In total, 6 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €65k. History available since 17 August 2021. The latest transaction was filed on 1 July 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Deepika Jalota is the Senior Vice President of Regulatory Affairs and Quality Assurance at PMV Pharmaceuticals, Inc. She oversees regulatory and quality activities, ensuring that the company's products meet industry standards. Her expertise is essential for the company's success.